Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane in hormone refractory metastatic prostate cancer
NCT00284752Phase 2Completed
- Sponsor
- Kaiser Permanente
- Start
- Aug 2005
- Primary completion
- Oct 2007
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in prostate cancer (PCa), sponsored by Kaiser Permanente. Started Aug 2005; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00284752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00284752.